AlphaFold predicted structure
CTBP1 · Q13363

Mean pLDDT
83.3/ 100
Confident
440 residues
Confidence breakdown
- Very high(≥ 90)74%
- Confident(70–90)1%
- Low(50–70)2%
- Very low(< 50)23%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
C-terminal binding protein 1
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Ataxia and cerebellar anomalies - narrow panel
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownDDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownMitochondrial disorders
hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome
type 2 diabetes mellitus
hereditary disease
diabetes mellitus
Intellectual disability
gestational diabetes
gout
diabetic retinopathy
diabetic eye disease
gastroesophageal reflux disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
C-terminal-binding protein 1
Corepressor targeting diverse transcription regulators such as GLIS2 or BCL6. Has dehydrogenase activity. Involved in controlling the equilibrium between tubular and stacked structures in the Golgi complex. Functions in brown adipose tissue (BAT) differentiation
CTBP1 · Q13363

Mean pLDDT
83.3/ 100
Confident
440 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0